Lipocine Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
LPCN on Nasdaq
Location
675 Arapeen Drive, Suite 202, Salt Lake City, X1

There are no Buy or Sell transactions made by insiders since 11/5/2023

Lipocine Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mahesh V. Patel CEO and President, Director $565K Mar 8, 2024
John W. Higuchi Director $77.1K Jun 5, 2024
Richard Dana Ono Director $77.1K Jun 5, 2024
Jeffrey Fink Director $77.1K Jun 5, 2024
Morgan R. Brown Chief Financial Officer $46.7K Dec 7, 2021
Spyros Papapetropoulos Director $38.1K Jun 5, 2024
Jill M. Jene Director $38.1K Jun 5, 2024
George Nomikos Chief Medical Officer $33.2K Nov 1, 2022
Krista Fogarty Principal Accounting Officer $8.69K Mar 8, 2024

Recent Insider Transactions by Companies or Individuals for Lipocine Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.